Acrux (ASX:ACR) Buyback Yield %: 0.97 (As of Jul. 01, 2026)


What is Acrux Buyback Yield %?

Acrux ASX:ACR -7.69% Buyback Yield % is 0.97 as of Jul. 01, 2026. The stock has 6 warning signs investors should review. Among 742 Biotechnology companies, Acrux ranks better than 92.72% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Acrux's current buyback yield was 0.97%.

Acrux Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Acrux's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acrux Buyback Yield % Chart

Acrux Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -48.19 0.00 0.00 0.00 -51.75

Acrux Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -25.97 -51.75 1.15

ASX:ACR vs VRTX, REGN, ALNY: Buyback Yield % Comparison

For the Biotechnology subindustry, Acrux's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Acrux Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Acrux's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Acrux's Buyback Yield % falls into.


Acrux Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Acrux's Buyback Yield for the fiscal year that ended in Jun. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 3.376) / 6.524224
=-51.75%

Acrux's annualized Buyback Yield for the quarter that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + -0.071) / 6.159135
=1.15%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of 0.97 mean?
Acrux (ASX:ACR) has a Buyback Yield % of 0.97 as of Jul. 01, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Acrux and its competitors. According to the industry distribution chart, Acrux ranks #54 out of 742 companies in the Biotechnology industry, placing it in the top 7.3%.
Is Acrux's Buyback Yield % too high?
Acrux's current Buyback Yield % is 0.97. Based on the distribution chart, Acrux ranks #54 out of 742 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers.
How does Acrux's Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Acrux ranks #54 out of 742 companies for Buyback Yield %. This places Acrux in the top 7% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Acrux and its competitors. Acrux's current Buyback Yield % is 0.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acrux stock overvalued right now?
Based on GuruFocus' analysis, Acrux (ASX:ACR) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.03, compared to a current price of A$0.01 — trading 60% below its estimated fair value. The current Buyback Yield % is 0.97. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Acrux (ASX:ACR), the current Buyback Yield % is 0.97 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Acrux Business Description

Other Exchanges ARUXF:USAFJY:Germany
Address 103-113 Stanley Street, West Melbourne, Melbourne, VIC, AUS, 3003
Acrux Ltd is a dynamic Australian drug delivery specialist with expertise in developing and commercialising patient-preferred healthcare products for world-wide markets. Its talent creates value through the development and commercialisation of healthcare products using owned or acquired technologies. The group's products are patient preferred, protected by patent or other means, and use creative drug delivery.